RPG Life Sciences Ltd. (RPGLIFE): RPG Life Sciences 52 Week High Streak: RPGLIFE Trades Near Peak for Second Straight Session

RPG Life Sciences 52 Week High Streak is now in its second straight session, with the stock trading within 2% of its one-year peak and showing a 4.06% cumulative move across the streak. The latest high in this stretch stood at Rs 3,122.75 and the share price last traded at Rs 3,072.55. The latest Univest figures confirm the price pattern, but they do not establish a company-specific catalyst for the repeated near-high action.

At 30 September 2026 at 9:22 AM IST, RPGLIFE was trading below its previous close of Rs 3,090.10, after opening at Rs 3,122.75 and touching a low of Rs 3,062.80. The company’s market capitalisation stood at Rs 4,883.64 crore. For readers, the repeated near-high pattern is more informative than a single-day move because it shows the stock has stayed close to its yearly peak across multiple sessions rather than only printing one isolated spike.

RPG Life Sciences Ltd. (RPGLIFE) 52 Week High Streak: Consecutive High Analysis

Metric	Value
Current Price	Rs 3,072.55
Previous Close	Rs 3,090.1
Today's Move	Rs -17.55 (-0.57%)
Open	Rs 3,122.75
High	Rs 3,122.75
Low	Rs 3,062.8
Market Capitalisation	Rs 4,883.64 crore

RPG Life Sciences Ltd. (RPGLIFE) traded at Rs 3,072.55 versus the previous close of Rs 3,090.1, a fall of 0.57%. The stock opened at Rs 3,122.75, reached a high of Rs 3,122.75 and touched a low of Rs 3,062.8.

RPG Life Sciences share price today was Rs 3,072.55, down Rs 17.55 or 0.57% from the previous close. The stock opened at Rs 3,122.75, matched that level as the day high, and then eased to a low of Rs 3,062.80 while still remaining close to its one-year peak. That trading band keeps RPGLIFE in the conversation among stocks at one year high today, even though the latest print was below the prior close.

The move is best read alongside the streak itself. RPG Life Sciences stock news is now centred on the fact that the share price has stayed within a narrow distance of the 52 week high for two straight sessions. The stock market cap of Rs 4,883.64 crore places it among the notable names in the Healthcare universe, and the latest share price update shows that the market is still valuing the business near the top of its recent range. Because this article type is about repeated highs, the key point is not one intraday swing but the persistence of the near-peak pattern across sessions.

What the Repeated 52-Week Highs Show

The latest RPGLIFE 52 Week High Streak shows that the stock has been able to stay close to its yearly high for a second straight session, with a cumulative gain of 4.06% across the streak. That matters more than a single-day headline because the move spans multiple trading days and keeps the stock in the list of 52 week high stocks. The latest high in the streak remains Rs 3,122.75, which is the level investors are watching against the current share price.

What the repeated 52-week highs show is continuity rather than a one-off event. The data confirms the price pattern, but it does not confirm why the stock has held near the peak. So, while this is a clear RPGLIFE new one year high style setup, the reason for the back to back 52 week highs is not established by the price data alone. For investors tracking RPG Life Sciences stock performance, the key question is whether the share price can continue to trade near the yearly high without losing that range position.

RPG Life Sciences Ltd. (RPGLIFE) Fundamental Analysis

Metric	Value
Market Capitalisation	Rs 4,883.64 crore
P/E Ratio	44.38x
P/B Ratio	8.03x
ROE	20.28%
ROCE	26.99%
EPS	Rs 69.64
Book Value Per Share	Rs 384.61
Dividend Yield	0.78%

RPG Life Sciences Ltd. (RPGLIFE) fundamental metrics show P/E 44.38x, P/B 8.03x, ROE 20.28%, ROCE 26.99%. These figures provide context only and are not a buy or sell signal.

RPG Life Sciences Ltd. has a market capitalisation of Rs 4883.64 crore, which gives readers a sense of company size before judging valuation. On valuation, P/E at 44.38x, P/B at 8.03x should be read against the sector and peer benchmarks rather than as a standalone signal. Profitability is represented by ROE of 20.28% and ROCE of 26.99%, helping investors compare shareholder returns and capital efficiency. According to latest Univest data, additional metrics include EPS of Rs 69.64, book value per share of Rs 384.61, dividend yield of 0.78%, adding context to earnings, balance-sheet value and historical payout. Against the latest Univest same industry benchmark, these figures can be compared with benchmark median P/E of 28.2x, median ROE of 11.7%, median ROCE of 13.46%. These numbers explain the fundamental backdrop without converting the article into a buy or sell view.

Sector and Industry Context

Metric	Value
Sector	Healthcare
Industry	Pharmaceuticals & Drugs
Benchmark Scope	same industry
Company P/E Ratio	44.38x
Benchmark Median P/E	28.2x
Benchmark Average P/E	42x
Benchmark P/E Range	0x to 699.02x
Company P/B Ratio	8.03x
Benchmark Median P/B	2.87x
Company ROE	20.28%
Benchmark Median ROE	11.7%
Company ROCE	26.99%
Benchmark Median ROCE	13.46%
Company Market Capitalisation	Rs 4,883.64 crore
Benchmark Median Market Cap	Rs 773.14 crore

RPG Life Sciences Ltd. (RPGLIFE) is classified under sector: Healthcare and industry: Pharmaceuticals & Drugs.

RPG Life Sciences Ltd. (RPGLIFE) has a P/E ratio of 44.38x, which is above the benchmark median of 28.2x, a difference of +57.38%. P/E is a valuation multiple and is not, by itself, a buy or sell signal.

RPG Life Sciences Ltd. (RPGLIFE) has a ROE of 20.28%, which is above the benchmark median of 11.7%, a difference of +73.33%. RPG Life Sciences Ltd. (RPGLIFE) has a ROCE of 26.99%, which is above the benchmark median of 13.46%, a difference of +100.52%.

Track stocks reaching yearly peaks through the Univest 52-week-high screener. The peer table below provides the company-level comparison.

Peer Comparison

Company	Symbol	Market Cap (Cr)	P/E	P/B	ROE (%)	ROCE (%)
Gujarat Themis Biosyn Ltd.	GUJTHEM	5,263.33	108.11	5.02	17.41	18.16
SMS Pharmaceuticals Ltd.	SMSPHARMA	4,324.38	43.77	5.56	12.49	13.32
FDC Ltd.	FDC	5,581.94	19.48	2.18	11.81	15.93
Gufic Biosciences Ltd.	GUFICBIO	4,224.9	59.8	6.39	10.14	12.56
IOL Chemicals And Pharmaceuticals Ltd.	IOLCP	5,764.88	35.17	3.17	7.9	10.65

RPG Life Sciences Ltd. (RPGLIFE) has a P/E ratio of 44.38x compared with the displayed peer median of 43.77x. This is a relative valuation comparison, not a buy or sell signal. Its ROE of 20.28% compares with a peer median of 11.81% across the companies shown in the table. ROCE stood at 26.99% versus the displayed peer median of 13.32%, providing a capital-efficiency comparison. RPG Life Sciences Ltd. (RPGLIFE) has a market capitalisation of Rs 4,883.64 crore. Among the 5 peers shown, 3 have a larger market capitalisation.

Why Investors Are Watching RPG Life Sciences

• RPG Life Sciences 52 Week High Streak has extended to a second straight session.
• The share price is still trading close to the one-year high.
• The cumulative streak move stands at 4.06%.
• RPG Life Sciences fundamental analysis shows ROE of 20.28% and ROCE of 26.99%.
• Valuation remains above the industry median on both P/E and P/B.

About RPG Life Sciences Ltd.

RPG Life Sciences Ltd. operates in the Pharmaceuticals & Drugs industry within Healthcare. The company’s latest share price update places it at a market capitalisation of Rs 4,883.64 crore, with the share price trading near its 52-week peak and attracting attention among stocks at one year high today. For readers tracking RPG Life Sciences company news, the main takeaway is the mix of a near-high streak, stronger return ratios and a premium valuation versus the industry median.

The stock is listed on NSE and BSE, and the current market update shows that RPGLIFE remains close to its recent peak rather than drifting far below it. That keeps the name on the radar for investors comparing share price, market capitalisation, valuation and sector positioning across healthcare companies.

FAQ:

Frequently Asked Questions

What is the RPG Life Sciences 52 Week High Streak right now?

Ans. RPG Life Sciences 52 Week High Streak is in its second straight session. The stock has traded within 2% of its 52-week high across that stretch, which keeps RPGLIFE in focus among stocks hitting 52 week highs.

How much has RPGLIFE moved across the streak?

Ans. The cumulative move across the RPG Life Sciences 52 Week High Streak is 4.06%. That figure reflects the full streak period, not just one trading day, and it is the key differentiator for this article.

Did RPGLIFE set a new 52-week high today?

Ans. The stock traded near its 52-week high, but the latest figures do not show that it set a new yearly high in this session. The latest high in the streak stood at Rs 3,122.75.

What was the latest price action in RPGLIFE share price today?

Ans. RPGLIFE last traded at Rs 3,072.55, below the previous close of Rs 3,090.10. The day’s range ran from Rs 3,062.80 to Rs 3,122.75, which kept the stock close to its yearly peak.

Is a company-specific catalyst confirmed for the repeated highs?

Ans. No company-specific catalyst is confirmed by the latest price pattern alone. The data confirms the repeated near-high setup, but it does not establish why the stock kept trading close to its one-year high.

How does the stock compare on valuation?

Ans. RPGLIFE trades at a P/E of 44.38 and a P/B of 8.03, both above the industry medians of 28.2 and 2.87. That places the stock at a premium to many peers in the Pharmaceuticals & Drugs group.

What do the return ratios show in RPG Life Sciences fundamental analysis?

Ans. The company reports ROE of 20.28% and ROCE of 26.99%. Those ratios are above the industry medians in the latest snapshot and support the fundamental analysis of the stock.

What should investors monitor next in RPGLIFE?

Ans. Investors should monitor whether the share price continues to trade near the 52-week high, how the valuation compares with peers, and whether the next price action keeps RPGLIFE inside the same near-peak band.

Track RPG Life Sciences Ltd. (RPGLIFE) Share Price on Univest

Use RPG Life Sciences Ltd. (RPGLIFE) live share-price page, Univest 52-week-high screener, Univest market blogs to review live stock data, yearly-high lists and related market analysis.